Autologous HER2-specific/EGFRt-expressing CD4/CD8-positive CAR T-cells - CISMeF
Autologous HER2-specific/EGFRt-expressing CD4/CD8-positive CAR T-cellsNCIt concept
Preferred Label : Autologous HER2-specific/EGFRt-expressing CD4/CD8-positive CAR T-cells;
NCIt synonyms : Autologous HER2 CAR/EGFRt-expressing CD4 and CD8 T-cells;
NCIt definition : A preparation of CD4 and CD8 autologous T-lymphocytes transduced with a lentiviral
vector expressing a human epidermal growth factor receptor type 2 (HER2; EGFR2; ErbB2)-specific
chimeric antigen receptor (CAR) coupled to a truncated form of the human epidermal
growth factor receptor (EGFRt), with potential immunostimulating and antineoplastic
activities. Upon intravenous administration, the autologous HER2-specific/EGFRt-expressing
CD4/CD8-positive CAR T-cells are directed to and induce selective toxicity in HER2-expressing
tumor cells. Devoid of both ligand binding domains and tyrosine kinase activity, the
expressed EGFRt both facilitates in vivo detection of the administered, transduced
T-cells and can promote elimination of these cells through an anti-EGFR antibody-induced
antibody-dependent cellular cytotoxicity (ADCC) response. HER2, a receptor tyrosine
kinase (RTK) overexpressed by a variety of tumor cell types, belongs to the EGFR superfamily
and plays a key role in tumor cell proliferation.;